Safety profile of fluticasone propionate HFA in pre-school age children with asthma

Safety assessments included: adverse events (AEs), clinical labs, oropharyngeal/nasal exams, asthma exacerbations, and 12-hour, overnight urinary cortisol excretion (U-Cortisol).

Saved in:
Bibliographic Details
Published inJournal of allergy and clinical immunology Vol. 115; no. 2; p. S211
Main Authors Qaqundah, P.Y., Maspero, J., Ceruti, E., Scott, C.A., Clements, D.S., Wu, W., Crim, C.
Format Journal Article
LanguageEnglish
Published St. Louis Mosby, Inc 01.02.2005
Elsevier Limited
Subjects
Asthma
Drug therapy
Medical research
Online AccessGet full text

Cover

More Information
Summary:Safety assessments included: adverse events (AEs), clinical labs, oropharyngeal/nasal exams, asthma exacerbations, and 12-hour, overnight urinary cortisol excretion (U-Cortisol).
ISSN:0091-6749
1097-6825
DOI:10.1016/j.jaci.2004.12.854